← Back to Vaccine Database

Recombinant protein RBD fusion dimer adjuvanted vaccine (COVID-19 Vaccine Hipra)

Protein based vaccine · VDDBV0640

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials5

NCT IDPhaseDisease / Condition
NCT05007509 Phase 2COVID-19
NCT05142514 Phase 2COVID-19
NCT05142553 Phase 2COVID-19
NCT05305573 Phase 2COVID-19
NCT05246137 Phase 3COVID-19